Two oral antihyperglycemic drugs with different and complementary mechanisms of action are combined to improve glycemic control in patients with type 2 diabetes: canagliflozin, a SGLT2 transporter inhibitor, and metformin hydrochloride, a member of the biguanide group.
Leave your review